Renalytix Plc (RNLXY)
2.71
-0.06
(-1.99%)
USD |
OTCM |
Aug 21, 16:00
Renalytix Shareholders Equity (Quarterly)
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | -1.369M |
| September 30, 2024 | -11.32M |
| June 30, 2024 | -7.854M |
| March 31, 2024 | -11.11M |
| December 31, 2023 | -7.956M |
| September 30, 2023 | -1.491M |
| June 30, 2023 | 6.967M |
| Date | Value |
|---|---|
| March 31, 2023 | 18.10M |
| December 31, 2022 | 8.885M |
| September 30, 2022 | 18.84M |
| June 30, 2022 | 30.61M |
| March 31, 2022 | 29.42M |
| December 31, 2021 | 45.80M |
| September 30, 2021 | 59.97M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CompuMed, Inc. | 3.026M |
| Quest Diagnostics, Inc. | 7.516B |
| Labcorp Holdings, Inc. | 8.607B |
| Myriad Genetics, Inc. | 303.90M |
| OPKO Health, Inc. | 1.184B |